Low-dose chemotherapy is being studied/used in the treatment of cancer to avoid the side effects of conventional chemotherapy. Historically, oncologists have used the highest doses that can be tolerated by the body to kill as many cancer cells as possible. After high-dose treatment, the body reacts, sometimes quite badly. Infection from external causes becomes the main threat of death.
Video Low-dose chemotherapy
Bentuk kemoterapi dosis rendah
The following forms of low-dose chemotherapy have been proposed. They are not always available in hospital care.
Oral low-dose chemotherapy
Patients are given oral chemotherapy drugs very often. This approach can be very effective for some cancers and can minimize side effects for some people. More patients use oral chemotherapy than before.
Low-dose chemotherapy and antiangiogenesis
Adam Dicker, a professor at Jefferson Medical College from Thomas Jefferson University in Philadelphia, supports that chemotherapy is often used in the highest doses. They rethink chemotherapy because of the low-dose antiangiogenic effects of chemotherapy given more often than conventional chemotherapy. They have shown excellent antiangiogenic results in the laboratory.
Therapy therapy for low-dose chemotherapy insulin therapy
Although not yet proven, advocates of potential insulin therapy (IPT) suggest that insulin modifies the acceptance of cancer cells to be penetrated by chemotherapy. Cancer cells secrete their own insulin and growth factors such as insulin (IGF) that work together to consume the body's nutrients to grow cancer. The cancer cell membrane has about sixteen times more insulin and IGF receptors than normal cells, and these receptors react with synthetic insulin. When insulin is administered, the cancer divides glucose and produces enzyme activity that makes the cell membrane more permeable. Chemotherapy drugs are absorbed by cancer. Using the same mechanisms that cancer cells use to grow and kill people, proponents believe IPT delivers direct chemotherapeutic drugs in cancer cells leaving only normal cells.
Insulin therapy is not the same as low-dose IPT chemotherapy. Insulin itself modulates the transport of nutrients and more throughout the body. There have been several attempts to use insulin in a variety of proven functions. In biologic cancer therapy, insulin potentiation therapy can be used to manage mandelonitrile (B17) as a first step for low-dose IPT chemotherapy.
Maps Low-dose chemotherapy
Research
There are many other researchers looking for low-dose chemotherapy treatments.
Footnote
Source of the article : Wikipedia
0 Comments